HONG KONG, 11 September 2025 – Lianhe Ratings Global Limited (“Lianhe Global”), an international credit rating company, has affirmed ‘A-’ global scale Long-term Issuer Credit rating of Taizhou Huaxin Pharmaceutical Investment Co., Ltd. (“THPI” or “the company”). The Outlook is stable.